Pharmakologie (Abt. II)

Publikationen von Kenneth Anthony Roquid

Zeitschriftenartikel (5)

2023
Zeitschriftenartikel
Bonnavion, R.; Liu, S.; Kawase, H.; Roquid, K. A.; Offermanns, S.: Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5). FRONTIERS IN PHARMACOLOGY 14, 1297596 (2023)
Zeitschriftenartikel
Nakayama, A.; Roquid, K. A.; Iring, A.; Strilic, B.; Guenther, S.; Chen, M.; Weinstein, L. S.; Offermanns, S.: Suppression of CCL2 angiocrine function by adrenomedullin promotes tumor growth. JOURNAL OF EXPERIMENTAL MEDICINE 220 (1), e20211628 (2023)
2021
Zeitschriftenartikel
Le Mercier, A.; Bonnavion, R.; Yu, W.; Alnouri, M. W.; Ramas, S.; Zhang, Y.; Jaeger, Y.; Roquid, K. A.; Jeong, H.-W.; Sivaraj, K. K. et al.; Cho, H.; Chen, X.; Strilic, B.; Sijmonsma, T.; Adams, R.; Schroeder, T.; Rieger, M. A.; Offemanns, S.: GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 118 (17), e2021596118 (2021)
2020
Zeitschriftenartikel
Nakayama, A.; Albarran-Juarez, J.; Liang, G.; Roquid, K. A.; Iring, A.; Tonack, S.; Chen, M.; Mueller, O. J.; Weinstein, L. S.; Offermanns, S.: Disturbed flow-induced G(s)-mediated signaling protects against endothelial inflammation and atherosclerosis. JCI INSIGHT 5 (23), e140485 (2020)
Zeitschriftenartikel
Roquid, K. A. R.; Alcantara, K. M. M.; Garcia, R. L.: Identification and validation of mRNA 3 ' untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN. INTERNATIONAL JOURNAL OF ONCOLOGY 56 (2), S. 544 - 558 (2020)
Zur Redakteursansicht